Chandrima Sanyal
ProShares Ultra Gold
UGL · ETF
$41.98−$0.65 (−1.52%)TodayMarket closed ·
Prev close $42.63
About UGL
- Issuer
- ProShares
- Tracks
- Bloomberg Gold Subindex
- Expense ratio
- 0.95%
- Assets under management
- $716.51M
- Inception
- Dec 1, 2008
- Asset class
- Commodities
- Website
- proshares.com
UGL key statistics
- Market cap
- 0
- Price-earnings ratio
- 0.00
- Average volume
- 2.65M
- Volume
- 2.87M
- Open price
- $42.57
- High today
- $42.63
- Low today
- $41.49
- 52 Week high
- $90.40
- 52 Week low
- $42.42
ProShares Ultra Gold (UGL) at a glance
As of Oct 23, 2026, ProShares Ultra Gold (UGL) shares are priced at $41.98, giving the company a market cap of 0 and a price-to-earnings ratio of 0.00.
Today the fund has traded between $41.49 and $42.63. The current price is 1.2% above the day's low and 1.5% below its high.
Volume so far is 2.87M shares, in line with the average of 2.65M shares a day.
Over the past year ProShares Ultra Gold has ranged from $42.42 to $90.40, and now sits -1% of the way up that range.
UGL news
- Chandrima Sanyal
Are Gold ETFs Really A Hedge During A Geopolitical Crisis? Here's What To Check Before Investing
- Press releaseBusiness Wire
ProShares Announces ETF Share Splits
- Piero Cingari
Gold Price Soars To Record Highs, Eyes Best 2-Month Rally Since 2011 On Blockbuster ETF Buying
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0002+0.00%
- GTVHGolden Triangle Ventures$0.0002+100.00%
- TMSHTrans Global Assets$0.0003+20.00%
- RDARRaadr$0.0002+0.00%
- GPUSHyperscale Data$0.1689+34.05%
- SEIISharing Economy International$0.0002−33.33%
- ELMEElme Communities$1.77+0.57%
- SHFSSHF Holdings$0.1324−61.39%
- XXII22nd Century Group$0.1977−8.34%
- NBNDNetBrands$0.0006−40.00%
- NVDGraniteShares ETF Trust$4.19+0.96%
- HIRUHiru$0.0006+9.09%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.49−0.10%
- CTYCITY THERAPEUTICS$20.77+0.00%
- IAMIambic Therapeutics$14.26−2.79%
- AMROAmaero$5.84+7.75%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.30+0.29%
- TRXBTRex Bio$13.81−10.90%
- RTSNRetension Pharmaceuticals$15.25−1.61%
- PAXGUPine Tree Acquisition$10.01+0.05%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.13−0.77%
- ACCVAccelevation Holdings$12.38+1.06%
- RZAIROZE AI$10.92−1.89%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.